Vanguard Group Inc Ardelyx, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,031,649 shares of ARDX stock, worth $104 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,031,649

Previous 14,997,234 6.9%

Holding current value

$104 Million

Previous $73.6 Million 14.66%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$3.28 - $5.51 $3.39 Million - $5.7 Million	1,034,415 Added 6.9%	16,031,649 $62.8 Million
Q1 2025 May 09, 2025	BUY	$4.91 - $6.36 $3.12 Million - $4.04 Million	634,575 Added 4.42%	14,997,234 $73.6 Million
Q4 2024 Feb 11, 2025	BUY	$4.49 - $6.85 $3.44 Million - $5.25 Million	767,111 Added 5.64%	14,362,659 $74.3 Million
Q3 2024 Nov 13, 2024	SELL	$5.28 - $7.57 $318,378 - $456,463	-60,299 Reduced 0.44%	13,595,548 $93.7 Million
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.31 $1.55 Million - $2.46 Million	263,992 Added 1.97%	13,655,847 $101 Million
Q1 2024 May 10, 2024	BUY	$6.05 - $9.74 $2.21 Million - $3.56 Million	365,809 Added 2.81%	13,391,855 $97.8 Million
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $4.8 Million - $9.7 Million	1,460,246 Added 12.63%	13,026,046 $80.8 Million
Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $323,238 - $473,103	97,951 Added 0.85%	11,565,800 $47.2 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $9.02 Million - $13.8 Million	2,793,144 Added 32.2%	11,467,849 $38.9 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $967,994 - $1.73 Million	361,192 Added 4.34%	8,674,705 $41.6 Million
Q4 2022 Feb 10, 2023	BUY	$1.22 - $2.85 $3.13 Million - $7.32 Million	2,567,995 Added 44.7%	8,313,513 $23.7 Million
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $300,251 - $732,817	508,901 Added 9.72%	5,745,518 $6.84 Million
Q2 2022 Aug 12, 2022	BUY	$0.51 - $1.17 $665,848 - $1.53 Million	1,305,586 Added 33.21%	5,236,617 $3.09 Million
Q1 2022 May 13, 2022	SELL	$0.65 - $1.18 $321,943 - $584,451	-495,298 Reduced 11.19%	3,931,031 $4.21 Million
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $397,992 - $786,729	462,782 Added 11.68%	4,426,329 $4.87 Million
Q3 2021 Nov 12, 2021	BUY	$1.27 - $8.17 $85,031 - $547,014	66,954 Added 1.72%	3,963,547 $5.23 Million
Q2 2021 Aug 13, 2021	BUY	$6.55 - $8.98 $25.5 Million - $35 Million	3,896,593 New	3,896,593 $29.5 Million

Others Institutions Holding ARDX

# of Institutions

222

Shares Held

167M

Call Options Held

517K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $1.01B
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ardelyx, Inc. Transaction History